CTRI/2014/11/005169已完成4 期
Comparative study of Atorvastatin and Rosuvastatin in combination with Fenofibrate in Hyperlipidemics
Mamata Medical College0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Low density lipoprotein cholesterol (LDL-C) higher than130 mg/dl
- •2. Triglycerides (TG) more than 250 mg/dl will be included in the study.
- •Patient with
- •3. Hypertension
- •4. Diabetes mellitus
- •5. Obesity and
- •6. Coronary artery disease will be included in the study.
排除标准
- •Patients with
- •1. Renal and hepatic failure
- •2. Pregnancy
- •3. Hypothyroidism
- •4. Malignancy
- •5. Myopathy
- •6. Patients who had undergone bypass surgery, and 7. Patients who are taking cardiac drugs like warfarin, verapamil and amiodarone will be excluded from the study.
研究者
相似试验
已完成
4 期
The effect of Atorvastatin and rosuvastatin on the Levels of 25 Hydroxyvitamin DPatient with Acute Coronary Syndrome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20190902044673N1eyshabour University of Medical Sciences80
已完成
不适用
Comparing the effects of Atorvastatin and Rosuvastatin in preventing acute kidney injury due to contrast mediaIRCT2017101236737N1Vice chancellor for research, Mashhad University of Medical Sciences200
招募中
2 期
Effects of atorvastatin and rosuvastatin on prevention of atrial fibrillatioParoxysmal atrial fibrillationAtrial fibrillation post coronary artery bypass graft.I48.0IRCT20191109045384N1Tabriz University of Medical Sciences200
尚未招募
2 期
Comparison of the efficacy of Atorvastatin and Rosuvastatin in atrial fibrillation incidence after coronary artery bypass graft surgery (CABG)Paroxysmal atrial fibrillationIRCT20201028049175N2Arak University of Medical Sciences104
已完成
3 期
statin and inflamatioIRCT20190903044682N1eyshabour University of Medical Sciences84